Fidelis Capital Partners LLC Acquires 306 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fidelis Capital Partners LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,155 shares of the healthcare conglomerate’s stock after purchasing an additional 306 shares during the period. Fidelis Capital Partners LLC’s holdings in UnitedHealth Group were worth $4,153,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Bell Investment Advisors Inc grew its holdings in shares of UnitedHealth Group by 4.8% in the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after buying an additional 24 shares during the period. Harbor Investment Advisory LLC increased its holdings in shares of UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after acquiring an additional 1,129 shares in the last quarter. Austin Private Wealth LLC lifted its holdings in shares of UnitedHealth Group by 9.8% during the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after purchasing an additional 111 shares in the last quarter. Capital Insight Partners LLC increased its stake in UnitedHealth Group by 3.8% during the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after purchasing an additional 332 shares in the last quarter. Finally, Collective Family Office LLC lifted its stake in UnitedHealth Group by 4.3% in the first quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock valued at $780,000 after buying an additional 65 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.4 %

Shares of UNH opened at $575.00 on Friday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $529.22 billion, a PE ratio of 35.15, a PEG ratio of 1.64 and a beta of 0.58. The stock’s 50-day moving average price is $577.10 and its two-hundred day moving average price is $520.80.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the firm posted $6.14 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.46%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s payout ratio is currently 51.34%.

Insider Buying and Selling at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on UNH. UBS Group boosted their price objective on shares of UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. HSBC upped their price objective on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. TD Cowen boosted their price target on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Finally, Argus upped their target price on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and a consensus price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.